Golden Cross
5年前
News - Matica CFO Retires
Press Release | 10/16/2019
TORONTO, ON / ACCESSWIRE / October 16, 2019 / Matica Enterprises Inc. (CSE:MMJ) (OTCQB:MMJFF) (Frankfurt:39N) ("Matica" or the "Company") announces that Mr. George A. Brown has taken early retirement for personal and health reasons and has resigned as Director and Chief Financial Officer effective October 15, 2019. We would like to thank him for his years of valuable service to the company. Mr. Brown joined Matica in 2015 and has been one of the driving forces in the success of the Company. His contributions and his presence will be greatly missed.
Mr. Gurcharn Deol, Director of Matica will act as interim CFO until a suitable replacement can be found.
About Matica
Matica is a multi-faceted, innovative company in the Quebec cannabis space. RoyalMax Biotechnology Canada Inc. has been granted a standard cultivation licence by Health Canada for the production facility in Dorval, Quebec. Matica intends to build 1,000,000 square feet of greenhouses, in 200,000 square foot increments, on a 181 acre property in the township of Hemmingford, south of Montreal. Matica has entered into an agreement with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for Matica and RoyalMax.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
Boris Ziger
Boris Ziger, CEO & Chairman
The Company's public filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, at:
Telephone: 416-304-9935
E-mail: info@maticaenterprises.com
Website: www.maticaenterprises.com , www.maticammj.com
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation's filings with the Canadian securities regulators, which filings are available at www.sedar.com.
This news release contains statements about the Company's information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.
SOURCE: Matica Enterprises Inc
View source version on accesswire.com:
https://www.accesswire.com/563207/Matica-CFO-Retires
TeddySaidit
6年前
500 clones of Sensi Star arrived today
44 Victoria St. Suite 1102
Toronto, ON, M5C 1Y2
Tel: (416) 304-9935 F: (604) 638-0973
Email: info@maticaenterprises.com
Web: www.maticaenterprises.com
MMJ - (Canada) | 39N - (Frankfurt) | MQPXF - (OTC)
DORVAL RECEIVES SECOND SHIPMENT OF CLONES - REVISED
February 21, 2019 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MQPXF – OTC) (“Matica” or the “Company”) is pleased to announce that the Dorval growing facility has received its second shipment of rooted starting materials. 500 clones of Sensi Star arrived today from THC BioMed. This is our second shipment from THC BioMed. The first clones arrived in January (NR, Jan. 23, 2019) and have been in the vegetation room since February 6th.
About Matica
Matica is a multi-faceted, innovative company in the Quebec cannabis space. RoyalMax Biotechnology Canada Inc. ("RoyalMax") was recently granted a cultivation licence by Health Canada for the production facility in Dorval, Quebec. RoyalMax is one of only 11 Licensed Producers in the Province of Quebec. Matica intends to build 1,000,000 square feet of greenhouses on a 181 acre property in the township of Hemmingford, south of Montreal. Matica has entered into an agreement with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
Boris Ziger
Boris Ziger, CEO & Chairman
Jdoggg
6年前
FTMIG Interviews Boris Ziger, CEO of Matica Enterprises Inc! (CNX: MMJ)
https://www.ftmig.com/portfolio-view/ftmig-interviews-boris-ziger-ceo-of-mmj/
Boris Ziger, CEO of Matica Enterprises, joins us live today to discuss what's on the horizon now that they have received their cultivation license from Health Canada, and to showcase their first unique and proprietary product for the consumer market developed by Yunify Natural Technologies! #MMJ #MQPXF
LIVE STREAM of our show will be available on our FTMIG LIVE page at the following link: https://www.facebook.com/Followthemoneyinvestorgroup
TUNE IN every Wednesday from 1-3pm EST on Midas Letter (midasletter.com) where we bring you the most current interviews, special guests, T.A., and discussions on the most interesting companies in the hottest sectors.
Join our FREE membership for access to EXCLUSIVE early-round investment opportunities!
** https://www.ftmig.com/membership
Built by investors, for investors. Be in the know and FOLLOW THE MONEY!
FULL VIDEOS will also be available on our website at www.ftmig.com and don’t forget to Like, follow, and share our FTMIG LIVE page, YouTube, and Twitter for all our exclusive videos and updates!!
https://www.twitter.com/FTMInvestment
https://www.YouTube.com/Followthemoneyinvestorgroup
https://www.Facebook.com/followthemoneyinvestorgroup
https://www.ftmig.com/portfolio-view/ftmig-interviews-boris-ziger-ceo-of-mmj/
3-Stooges-Nyuk-Nyuk-Nyuk
6年前
news : June 4, 2018
Here is a translation of the article: Major investment in Hemmingford: $ 12 million for the construction of cannabis greenhouses Photo by Jacques Larochelle Jacques Larochelle jacques_larochelle@coupdoeil.info Wednesday, July 4, 2018, 6:00 am Comment Major investment in Hemmingford: $ 12 million for the construction of cannabis greenhouses A typical greenhouse for the production of medicinal cannabis. Photo credit: courtesy A text by Jacques Larochelle Economy - Matica Enterprises of Toronto will build one million square feet of greenhouses in Hemmingford Township for medicinal marijuana production. The first phase of the project, which begins these days, consists of the construction, at a cost of $ 12 million, of 200,000 square feet of greenhouses on a five acre acreage on a 181 acre property. Purchased by Matica, this land is on Back Bush Road between Route 219 and Rang 3. It is actually the former Gravel Orchard. The company has received support from the Municipality of Hemmingford Canton who has been supportive of the project and very cooperative. Mayor Paul Viau said he was welcome because cannabis will be legal in the coming months and Matica has an excellent project. For now, it will be medicinal marijuana, but recreational cannabis production may come later. The law legalizing cannabis in Canada was passed by the House of Commons on June 18. Marijuana will be allowed for recreation as of October 17. Boom in Canada Matica says it chose Hemmingford Canton, because it has an ideal microclimate for cultivation, that access to groundwater and a 600 amp power line is readily available, that it is close to Montreal, and that the Land price is reasonable. The greenhouses will measure 100 feet long by 42 feet wide. In the coming weeks, the land will be developed and at least 25 greenhouses are expected to be built by the end of October. If the project is complete, we are talking about nothing less than 250 greenhouses! Matica was particularly interested in starting cannabis production in Quebec because there are only six companies that have Health Canada production licenses in the province compared to 59 in Ontario. The market potential is therefore very important. In total, just over 100 permits for the production of medicinal cannabis have been issued so far for the entire country. The $ 12 million of the first phase of the project, which will create about 50 full-time and part-time jobs, is just the beginning. The staff will be recruited mainly in agricultural schools. For now, the investment is modest, as already known projects, such as that of the company MYM Nutraceuticals in Weedon, Quebec, are valued at $ 200 million for a production area of 1.5 million square feet. The company is talking about creating more than 400 jobs. For its part, Hydropothicaire, already established in Gatineau, announced last December to invest $ 80 million to add a new greenhouse of one million square feet and become the largest producer of cannabis in Canada within three years. Matica Enterprises president Boris Ziger and chief financial officer George Brown on the grounds of Back Bush Road will soon see the construction of dozens of greenhouses for medicinal cannabis cultivation. Business in transformation Matica is a company that has a long history of mining exploration. She has now redeployed into cannabis production, an area where she wants to carve out an important place. On March 22, she reported taking a $ 2 million stake in Yunify Natural Technologies, a Saint-Hubert-based company specializing in the development of products such as skin creams and balms, nutraceuticals (made from food substances, such as garlic capsules that come from garlic), and nutrients for plants. She has expertise in the extraction of cannabis substances for medical use in particular. Matica will sell its production to Yunify, which will build new laboratories on or around the Hemmingford Canton property for processing. And it is Matica who, thanks to its license from Health Canada, will sell the products thus manufactured. A few months earlier, Matica had taken a 70% stake in RoyalMax Biotechnology Canada, which has a 10,000 square foot production center in Dorval. The recent renovation of the building will help cultivate medicinal cannabis. Based on the latest available financial information, Matica Enterprises has a market capitalization of $ 57 million. The company claims to be in excellent financial health and very well placed to take a leadership role in the production of medicinal cannabis and marijuana derivatives in Canada. The project in Hemmingford Canton will be very interesting to follow.
3-Stooges-Nyuk-Nyuk-Nyuk
7年前
From one of the other boards... LOL pretty funny and true..
Matica -the ugly site
After few days away from reading the soap opera happening on MMJ board i am back just to find out the same old comments writen by people who register with SH in March 2018.
So for those who visited MMJ board....
Dear MMJ board reader
For those who expect to get any information related to the company and their activities you will be struck by vulgarity and low investment education by many of the posters .Most of the SH posters on MMJ board are SH members signed recently in 2018 (with few exceptions). and we can only speculate as to the reason behind it. In search of any meaningful info you will be reading msg after msg unrelated to the company but filled with profanity and absolutely lucking any common investors knowledge ..
It also seems like the company itself is not interested in providing any substantial information to any potential investors/shareholders.
When it comes to MMJ Dorval property ,their licensing process or any of their LOI status there is no factual information that could be considered reliable to the investors .
After finally completing (after multiple delays) their facility in Dorval, you will not find a person with knowledge ( no official press release) as to what is the actual size of the grow rooms,estimated cost,estimated profit,and even what is their estimated cannabis production per year...
Multiple visits by their CEO Boris and inexperienced promo group FTM who did the interview and tour of the facility for MMJ, did not include and did not provided any useful information which would clarify and give possible investors reason to buy and hold their MMJ shares .Those who decided to hold their shares after the stock run to .80 cents in early January were left with empty promises of great future business posted by Matica Ceo Boris Ziger on his Tweeter and by people who subscribe to the PP at 3-10 cents ,
Meantime ,the stock continue losing its ground and is now down almost 60% of its value since January 2018 when the stock reached the 52 week high and is now under performing the other MJ stocks,
Shareholders are being keep in dark as to the licensing process/status ,cash position, or ballooning shares structure estimated at over 315 000 000 shares out while the MMJ management continue to issue cheap options to them self as a form of compensation and to people connected to them.
Many shareholders are dumping their shares upset with the way the company is being run and are unable to justify their investment in MMJ.
So, with so many unanswered questions the remained shareholders who hope to recoup their losses have no ammunition to defend MMJ on SH from people who doubt the management integrity and their compensation system .So called "well informed" promising big profit or any news has failed to attract any new investors or even bring interest of day traders with their unproven and unsupportable stories .
Instead of demanding more action from the company, shareholders are focusing on verbal exchange with those who question the MMJ market cap,valuation,luck of news, and extremely poor public relations of MMJ management.
It almost seems like the shortcoming of the MMJ management match perfectly the type of investors who are posting on SH MMJ board .
In the end,luck of management professionalism and luck of reliable information is hurting both ,the one who bought the shares and the stock price.
The guys in the MMJ office are still well off......
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.mmj&postid=27717034#37j4gvkqYY2T6Put.99
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Renee
3年前
N_D_K_Hey
7年前
Marknel83
7年前
Rob~daBanca
7年前
